Biotech Values

[walldiver]

<<According to DNA, hardly anyone is actually being denied reimbursement for off-label Avastin.>>

One is one too many.

<<I don’t understand your point—what do the FDA’s actions on the sBLA have to do with the availability of Avastin in other countries?>>

I'm sure that there is at least one foreign country where Avastin approval has been delayed as a result of the Pazdur decision. FDA's stamp of approval goes a long way internationally. At least the EU has more common sense than Dr. P.